Polypore International Inc.  (PPO) Trade Now »     Rate PPO  -  Discuss PPO  -  Add to Watch List        

Home

Analysis & Videos

Quotes

Bull or Bear

Discuss

PPO: Bull or Bear?

From:    SocialPicks  |  Blogsphere  |  All

SocialPicks Community

Polypore International Inc. PPO

62%

+38.52% in 184 days NALYST RECOMMENDATIONS AND REVISIONS 1-5 Linear Scale Current 1 Month Ago 2 Month Ago 3 Month Ago (1) BUY 4 3 3 2 (2) OUTPERFORM 0 1 1 1 (3) HOLD 3 2 2 3 (4) UNDERPERFORM 0 0 0 0 (5) SELL 0 0 0 0 No Opinion 0 0 0 0 Mean Rating 1.86 1.83 1.83 2.17 Polypore International, Inc. (Polypore International) is a global high technology filtration company, that develops, manufactures and markets specialized microporous membranes used in separation and filtration processes. The Company produces microporous membranes that contain millions of pores per square inch, enabling the management ... Continue reading »

From the Blogosphere

Exciting Times as ATVM Loan and ARRA Battery Grants Announced

The next few days are going to be a very exciting time in the energy storage and electric vehicle sectors because the Obama Administration is preparing to announce a series of major ATVM Loan and ARRA Battery Manufacturing Grant awards. President Obama will be in Elkhart, Indiana where he will presumably announce an ATVM loan to Navistar (NAV) and may announce some additional ATVM loans or ARRA battery grants. Vice President Biden will be in Detroit where he is scheduled to announce one or more ARRA battery grants and perhaps some ATVM Loans. Secretary Chu will be in Charlotte, North Carol... Continue reading »

Unusual 11 Mid-Day Movers 12/03: OGXI, PPO, BZH, GW Higher; IFX, HSNI, FCX, PALM Lower

OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) 76% HIGHER; announced positive survival results from a randomized Phase 2 clinical trial of OGX-011 in combination with docetaxel and prednisone compared to docetaxel and prednisone alone for first-line treatment of metastatic castrate resistant prostate cancer. The current 10.6 month median overall survival advantage observed in the OGX-011 arm represents an increase over the median survival observed in the control arm. Docetaxel was approved by the FDA based on a survival advantage of 2.4 months over mitoxantrone.Polypore International Inc. (... Continue reading »

Monday's Upgrades and Downgrades

2 %

<> UPGRADES Microchip (MCHP)- AmTech Research Hold » Buy McKesson (MCK)- Leerink Swann Mkt Perform » Outperform Houston Wire & Cable (HWCC)- William Blair Mkt Perform » Outperform ITT Educational (ESI)- William Blair Mkt Perform » Outperform AMR Corp (AMR)- Soleil Sell » Buy Beazer Homes (BZH)- UBS Sell » Neutral Apollo Group (APOL)- Credit Suisse Neutral » Outperform Pepsi Bottling (PBG)- JP Morgan Underweight » Neutral Fifth Third (FITB)- Keefe Bruyette Mkt Perform » Outperform Cott (COT)- CIBC Wrld Mkts Sector Perform » Sector Outperform Port... Continue reading »

Monday's Upgrades and Downgrades

<> UPGRADES Microchip (MCHP)- AmTech Research Hold » Buy McKesson (MCK)- Leerink Swann Mkt Perform » Outperform Houston Wire & Cable (HWCC)- William Blair Mkt Perform » Outperform ITT Educational (ESI)- William Blair Mkt Perform » Outperform AMR Corp (AMR)- Soleil Sell » Buy Beazer Homes (BZH)- UBS Sell » Neutral Apollo Group (APOL)- Credit Suisse Neutral » Outperform Pepsi Bottling (PBG)- JP Morgan Underweight » Neutral Fifth Third (FITB)- Keefe Bruyette Mkt Perform » Outperform Cott (COT)- CIBC Wrld Mkts Sector Perform » Sector Outperform Port... Continue reading »

Analyst downgrades: IRF, WOSLY and PLD

Filed under: Analyst reports, Analyst upgrades and downgrades MOST NOTEWORTHY: International Rectifier, Wolseley and ProLogis were today's noteworthy downgrades: <> Citigroup downgraded shares of International Rectifier (NYSE: IRF) to Sell from Hold after checks in Asia indicated LCD TV display weakness outside Sony/Samsung and signs of slowing China consumer demand. Morgan Stanley downgraded shares of Wolseley (OTC: WOSLY) to Underweight from Equal Weight to reflect a more negative outlook for the company's Nordic business and U.S. housing starts. <>Banc of America cut ProLogis (NYSE:... Continue reading »

... more »  

None of the information contained on SocialPicks.com constitutes a recommendation by SocialPicks or its users that any particular security, portfolio of securities, transaction, or investment strategy is suitable for any specific person. SocialPicks is not responsible for the posts, discussions, and recommendations of the users on the Site. SocialPicks does not provide investment advice. You must make your own independent decisions regarding any security, portfolio of securities, transaction, or investment strategy mentioned on the website. SocialPicks' users' past results are not necessarily indicative of future performance. Neither SocialPicks nor any of its users guarantees any specific outcome or profit, and you should be aware of the real risk of loss in following any strategy or investments discussed on the website. You understand and agree that you use the Site and Services at your own discretion and risk and that you will be solely responsible for any damages that arise from such use. Before acting on any information contained on the website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.